Vichitra Behel

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 415 citations

Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2019 · 28 citations

Pemetrexed-carboplatin Chemotherapy, Gef Vs Gef+c, Medicine +15

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer

Vichitra Behel, Vanita Noronha, Anuradha Choughule et al. · JCO Global Oncology · 2022 · 25 citations · Full text

Catch-22: COVID versus Cancer

Vanita Noronha, Vichitra Behel · Cancer Research Statistics and Treatment · 2020 · 15 citations · Full text

Preventive Medicine, Cancer Epidemiology, Emerging Infectious Diseases +8

Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC

Vichitra Behel, Anuradha Chougule, Vanita Noronha et al. · Clinical Lung Cancer · 2022 · 13 citations

Oncology, Cancer Detection, Clinical Translation +10